Biotechnology - Legal, Financial


Current filters:


Popular Filters

US House of Representatives passes the American Research & Competitiveness Act

US House of Representatives passes the American Research & Competitiveness Act


By a vote of 274 to 131, US House of Representatives passed legislation (the American Research and Competitiveness…


US Court upholds damages award in Actelion/Asahi litigation


Switzerland-based Actelion says that the California Supreme Court has denied the firm’ petition for…

ActelionAsahi KaseiBiotechnologyfasudilFinancialLegalNorth AmericaRespiratory and PulmonaryUSA

PDL BioPharma settles litigation with Genentech and Roche


US drugmaker PDL BioPharma has entered into an agreement with Genentech and its parent, Swiss drug major…

BiotechnologyFinancialGenentechLegalOncologyOphthalmicsPDL BioPharmaRoche

Pharma associations strongly support Senate bill on FDA User Fees sequestration exemptions


In the USA last week, Mark Pryor (Democrat, Arkansas), chairman of the Senate Appropriations Subcommittee…

BiotechnologyFinancialGenericsLegalNorth AmericaPharmaceuticalPolitics

Bipartisan Bill exempting FDA user fees from sequestration introduced in USA


A bipartisan group of US House of Representatives Members last week introduced the FDA Safety Over Sequestration…

BiotechnologyFinancialLegalNorth AmericaPharmaceuticalPolitics

PDL files for arbitration for alleged royalties underpayments by Genentech


USA-based PDL BioPharma (Nasdaq: PDLI) revealed today (June 11) that it has filed a Notice of Arbitration…

BiotechnologyFinancialGenentechLegalPDL BioPharmaPharmaceuticalRoche

Amgen to pay $24.9 million to resolve false claims on Aranesp marketing


USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech company, has agreed to pay the…

AmgenAranespBiotechnologyFinancialLegalNorth America

US government takes steps to expose financial ties between drugmakers and doctors


After more than a year of prodding from the Senate Special Committee on Aging, the USA's federal government…

BiotechnologyFinancialLegalNorth AmericaPharmaceuticalResearch

News briefs: Celgene deal with Sutro; Amgen pleads guilty to misbranding


US biotech firm Celgene Corp (Nasdaq: CELG) has entered a collaboration with San Francisco-based Sutra…

AmgenAranespBiotechnologyCelgeneFinancialLegalLicensingNorth AmericaSutro Biopharma

Alnylam and Tekmira restructure relationship and settle all litigation in $65 million deal


USA-based Alnylam Pharmaceuticals (Nasdaq: ALNY) says it has restructured its relationship with Canadian…

Alnylam PharmaceuticalsBiotechnologyFinancialLegalLicensingPharmaceuticalTekmira Pharmaceuticals

US Senate passing of FDA Safety and Innovation Act lauded by biotech and pharma industry


The US Senate approved the Food and Drug Administration Safety and Innovation Act (FDASIA), which includes…

BiotechnologyFinancialLegalNorth AmericaPharmaceuticalPoliticsRegulation

US TREAT Act poised to revolutionize the biotechnology industry


In recent years, smaller biotechnology companies have received less funding from venture capitalists…

BiotechnologyFinancialLegalNorth AmericaRegulation

Back to top